An autopsy case of autoimmune meningoencephalitis caused by pembrolizumab
A 91-year-old man was on his seventh course of pembrolizumab for recurrence of right renal pelvic cancer. On the 8th day of treatment, he was admitted to the hospital with idiopathic fever and malaise. On the 12th day, the patient experienced tonic convulsions and exhibited an impaired consciousness...
Main Authors: | Yuhi Hiraoka, Takaharu Ichikawa, Norihiro Kusumi, Azusa Matsumi, Takahumi Sakuma, Tomoyasu Tsushima |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-11-01
|
Series: | Urology Case Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214442022002388 |
Similar Items
-
Retroperitoneal myofibroblastoma in an 88‐year‐old male
by: Shogo Watari, et al.
Published: (2022-09-01) -
Efficacy of urine loss ratio for prognosis of urinary continence after radical prostatectomy: A retrospective cohort study in a single Japanese institution
by: Shogo Watari, et al.
Published: (2023-03-01) -
Meningoencephalitis associated with GAD65 autoimmunity
by: Zuying Kuang, et al.
Published: (2023-03-01) -
Geriatric nutritional risk index as a prognostic marker of first-line immune checkpoint inhibitor combination therapy in patients with renal cell carcinoma: a retrospective multi-center study
by: Shogo Watari, et al.
Published: (2023-11-01) -
Hyperprogressive disease after treatment with pembrolizumab in lung adenocarcinoma: An autopsy case study
by: Yuko Tanaka, et al.
Published: (2019-01-01)